• Home
  • CuraTeQ Biologics

CuraTeQ Biologics

  • Synthetic Peptide APIs
About CuraTeQ Biologics

CuraTeQ Biologics is a biopharmaceutical company based in Hyderabad, India. We have a pipeline of 14 biosimilars of which: 3 products are filed with EMA, one product is filed with MHRA, and 4 products are in global Ph3 clinical trials. Dazublys™, our Trastuzumab biosimilar has received marketing authorization approval in India, and is also filed with EMA.

  • Auro Peptides, our synthetic peptides manufacturing arm, has filed 14 DMFs with US FDA that have contributed to 6 ANDA approvals.
  • CuraTeQ also offers end-to-end CDMO services for biopharmaceuticals (mAbs).

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IN
  • 2024
    On CPHI since
  • 250 - 499
    Employees
Company types
Biopharmaceutical company
CMO/CDMO
Generics/Biosimilars Manufacturer
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Pharmaceutical Company (generic finished products)
View company profile
Contact info
  • 9618569568
  • Website
  • CuraTeQ Biologics, , Survey No. 77 & 78, Indrakaran Village, Kandi Mandal, Sangareddy Distr, 502329, Hyderabad, Telangana, India
Show contact info Hide contact info

Products from CuraTeQ Biologics (2)

  • Biosimilars Portfolio

    Product Biosimilars Portfolio

    • Pegfilgrastim (Filed with EMA) • Filgrastim (Filed with EMA) • Trastuzumab (Filed with EMA, MHRA, Received recommendation for marketing authorization in India) • Bevacizumab (Filed with MHRA) • Omalizumab (Global PhIII ongoing) • Denosumab (Global PhIII ongoing) • Ranibizumab (Global PhIII ongoing...
  • Synthetic Peptide APIs Portfolio

    Product Synthetic Peptide APIs Portfolio

    US DMF Approved: • Vasopressin  • Icatibant acetate  • Leuprolide acetate  • Linaclotide  • Etelcalcetide  • Desmopressin  US DMF Filed: • Calcitonin salmon  • Ganirelix acetate  • Degarelix • Glatiramer acetate  • Plecanatide  • Teriparat...

CuraTeQ Biologics Resources (1)

  • Biosimilars Pipeline

    Brochure Biosimilars Pipeline

    CuraTeQ Biologics is a biopharmaceutical company based in Hyderabad, India. We have a pipeline of 14 biosimilars of which: 3 products are filed with EMA, one product is filed with MHRA, and 4 products are in global Ph3 clinical trials. Dazublys™, our Trastuzumab biosimilar has received marketing authorization approval in India, and is also filed with EMA.